Search research articles
Contact Us
Filters
Showing results (101-110 of 128) with videos related to
Page
of 13
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 20, 2015
Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma
Steven G DuBois, Susan Groshen, Julie R Park, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 22, 2018
Pulmonary Metagenomic Sequencing Suggests Missed Infections in Immunocompromised Children
Matt S Zinter, Christopher C Dvorak, Madeline Y Mayday, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 26, 2025
Addressing Knowledge Gaps in the Early Detection of Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation: An Official American Thoracic Society Research Statement
Guang-Shing Cheng, Ajay Sheshadri, Jane Turner, et al.
The Lancet. Oncology
|
December 4, 2013
Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial
Sung Won Choi, Thomas Braun, Lawrence Chang, et al.
The Lancet. Oncology
|
October 14, 2019
Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trial
Theodore W Laetsch, Gary Douglas Myers, André Baruchel, et al.
Transplantation and Cellular Therapy
|
April 6, 2021
Myeloablative Busulfan/Melphalan Consolidation following Induction Chemotherapy for Patients with Newly Diagnosed High-Risk Neuroblastoma: Children's Oncology Group Trial ANBL12P1
M Meaghan Granger, Arlene Naranjo, Rochelle Bagatell, et al.
Bone Marrow Transplantation
|
February 21, 2024
Overlap chronic GVHD is associated with adverse survival outcomes compared to classic chronic GVHD
Lev Gorfinkel, Sharmila Raghunandan, Benjamin Watkins, et al.
Transplantation and Cellular Therapy
|
April 7, 2024
The Adverse Event Landscape of Stem Cell Transplant: Evidence for AGVHD Driving Early Transplant Associated Toxicities
Takuto Takahashi, Benjamin Watkins, Brandi Bratrude, et al.
Blood
|
February 13, 2015
Lung parenchyma-derived IL-6 promotes IL-17A-dependent acute lung injury after allogeneic stem cell transplantation
Antiopi Varelias, Kate H Gartlan, Ellen Kreijveld, et al.
Transplantation and Cellular Therapy
|
March 29, 2023
Effect of Autograft CD34<sup>+</sup> Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors
Tristan E Knight, Kwang Woo Ahn, Kyle M Hebert, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 128) with videos related to
Sort By:
Page
of 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 20, 2015
Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma
Steven G DuBois, Susan Groshen, Julie R Park, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 22, 2018
Pulmonary Metagenomic Sequencing Suggests Missed Infections in Immunocompromised Children
Matt S Zinter, Christopher C Dvorak, Madeline Y Mayday, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 26, 2025
Addressing Knowledge Gaps in the Early Detection of Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation: An Official American Thoracic Society Research Statement
Guang-Shing Cheng, Ajay Sheshadri, Jane Turner, et al.
The Lancet. Oncology
|
December 4, 2013
Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial
Sung Won Choi, Thomas Braun, Lawrence Chang, et al.
The Lancet. Oncology
|
October 14, 2019
Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trial
Theodore W Laetsch, Gary Douglas Myers, André Baruchel, et al.
Transplantation and Cellular Therapy
|
April 6, 2021
Myeloablative Busulfan/Melphalan Consolidation following Induction Chemotherapy for Patients with Newly Diagnosed High-Risk Neuroblastoma: Children's Oncology Group Trial ANBL12P1
M Meaghan Granger, Arlene Naranjo, Rochelle Bagatell, et al.
Bone Marrow Transplantation
|
February 21, 2024
Overlap chronic GVHD is associated with adverse survival outcomes compared to classic chronic GVHD
Lev Gorfinkel, Sharmila Raghunandan, Benjamin Watkins, et al.
Transplantation and Cellular Therapy
|
April 7, 2024
The Adverse Event Landscape of Stem Cell Transplant: Evidence for AGVHD Driving Early Transplant Associated Toxicities
Takuto Takahashi, Benjamin Watkins, Brandi Bratrude, et al.
Blood
|
February 13, 2015
Lung parenchyma-derived IL-6 promotes IL-17A-dependent acute lung injury after allogeneic stem cell transplantation
Antiopi Varelias, Kate H Gartlan, Ellen Kreijveld, et al.
Transplantation and Cellular Therapy
|
March 29, 2023
Effect of Autograft CD34<sup>+</sup> Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors
Tristan E Knight, Kwang Woo Ahn, Kyle M Hebert, et al.
Page
of 13